BloombergNews

Recent Articles

Canada’s Supreme Court won’t hear Lilly appeal on Zyprexa

May 16, 2013
Eli Lilly claims recent decisions by Canadian courts invalidating 17 drug patents have made the country an outlier among major developed countries.
More

National fraternities face more legal risk after court ruling

May 15, 2013
An Indiana appeals court ruling regarding the death of a Wabash College freshman may force national fraternities to take more responsibility for misconduct at chapter houses.
More

Lechleiter's surgery to repair heart goes as planned

May 14, 2013
Eli Lilly and Co. CEO John Lechleiter underwent a scheduled surgery Monday for a heart defect, and the repair to the aorta is functioning as intended, the Indianapolis-based drugmaker said.
More

Three WellPoint directors step down, cite personal reasons

May 13, 2013
Lenox Baker, Sheila Burke and Susan Bayh resigned from the board effective immediately, Indianapolis-based WellPoint said Monday in a regulatory filing.
More

Lilly stops development on cancer drug after failed study

May 10, 2013
The drug, enzastaurin, was in the most advanced stage of testing and had been expected to generate $260 million in annual sales by 2018.
More

Duke Realty puts 17 Midwest office buildings on block

May 10, 2013
The developer is selling the buildings in Cincinnati, Cleveland and St. Louis to increase its emphasis on industrial properties. A research firm values them at $149 a square foot, or a total of about $350 million.
More

IU's Kelley School of Business getting new dean

May 9, 2013
Idalene Kesner will be the first woman to lead the school, and one of only a small handful of female business school deans in the United States.
More

More demand for mall space boosts Simon earnings

April 26, 2013
The Indianapolis-based owner of retail centers raised its expectations for the fiscal year after reporting solid gains in occupancy, rent revenue and earnings for the first quarter.
More

Lilly suing J&J for patent rights in Alzheimer's drug race

April 25, 2013
Eli Lilly and Co. is seeking to revoke a patent held by a Johnson & Johnson unit, arguing at a London court it might delay availability of a potential treatment for Alzheimer’s disease.
More

Dow AgroSciences grows sales, earnings to new heights

April 25, 2013
Record sales for seeds and new crop protection products helped boost revenue 14 percent at Indianapolis-based Dow AgroSciences LLC in its new fiscal year.
More
View All Articles
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT